Barber, Thomas M. and Franks, S (2013) Genetics of polycystic ovary syndrome. Frontiers of Hormone Research, 40 . pp. 28-39. doi:10.1159/000341682

Barber, Thomas M. and Franks, S. (2013) Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. Expert Review of Endocrinology and Metabolism, 8 (5). pp. 427-429. doi:10.1586/17446651.2013.827373

Barber, Thomas M. and Franks, S. (2013) The genetics of polycystic ovary syndrome. In: Macut, D. and Pfeifer, M. and Yildiz, B. O. and Diamanti-Kandarakis, E., (eds.) Polycystic Ovary Syndrome: Novel Insights into Causes and Therapy. Karger. ISBN 9783318022384

Barber, Thomas M., Vojtechova, P and Franks, S (2013) The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome. Hormone Molecular Biology and Clinical Investigation, 15 (3). pp. 91-103. doi:10.1515/hmbci-2013-0014

Ratheesh, Aparna, Priya, Rashmi and Yap, Alpha S. (2013) Coordinating Rho and Rac : the regulation of Rho GTPase signaling and cadherin junctions. Progress in Molecular Biology and Translational Science, 116 . pp. 49-68. doi:10.1016/B978-0-12-394311-8.00003-0

Sinha, Ranjeet K., Bojjireddy, Naveen, Kulkarni, Dakshayini, Ratheesh, Aparna, Chiplunkar, S.V., Gude, Rajiv and Subrahmanyam, Gosukonda (2013) Type II phosphatidylinositol 4-kinase β is an integral signaling component of early T cell activation mechanisms. Biochimie, 95 (8). pp. 1560-1566. doi:10.1016/j.biochi.2013.04.005

Sivaraman, S., Barber, Thomas M., O'Hare, P. and Randeva, H. S. (2013) Glucagon like peptide-1 based therapies : effects beyond blood glucose control. British Journal of Diabetes and Vascular Disease, 13 (5-6). pp. 229-237. doi:10.1177/1474651413504119